Skip to main content
S.Biomedics Co., Ltd. logo

S.Biomedics Co., Ltd. — Investor Relations & Filings

Ticker · 304360 ISIN · KR7304360001 KO Professional, scientific and technical activities
Open in API
Filings indexed 138 across all filing types
Latest filing 2024-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 304360

About S.Biomedics Co., Ltd.

https://www.sbiomedics.com/eng/

S.Biomedics Co., Ltd. is a company specializing in the research and development of cell therapies for regenerative medicine. Established in 2005, the company focuses on creating, manufacturing, and supplying stem cell-based therapeutic products. Its core activities involve leveraging data-driven biology to develop fundamental and safe treatments for various conditions, with a significant focus on neurodegenerative disorders such as Parkinson's disease. S.Biomedics is committed to advancing the field of stem cell therapy from initial research to clinical application.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for S.Biomedics Co., Ltd. covering the period from January 1, 2024, to September 30, 2024. It contains detailed company information, management history, capital changes, and business descriptions, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, as it provides substantive financial and operational data. 9M 2024
2024-11-14 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and is specifically marked as a 'Correction Report' (정정신고). This document details the terms of a capital raise through convertible bonds, including interest rates, conversion prices, put/call options, and the use of proceeds. This falls under the category of company fundraising and financing activities.
2024-11-13 Korean
증권발행결과(자율공시) (제5회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB) by S-Biomedics. It details the actual issuance amount, payment date, and confirms the completion of the financing activity. This falls under the category of capital and financing updates.
2024-11-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This document outlines the terms of the financing, including interest rates, conversion prices, put/call options, and the use of proceeds. In the context of Korean corporate filings, this is a standard regulatory disclosure regarding capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2024-11-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by S-Biomedics. This is a standard regulatory filing in South Korea for corporate financing activities, specifically capital structure changes involving debt-to-equity instruments. It details the terms of the bond, conversion rights, and use of proceeds, which falls under the 'Capital/Financing Update' category.
2024-11-07 Korean
불성실공시법인지정 (공시불이행)
Regulatory Filings Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the designation of S-Biomedics as an 'unfaithful disclosure corporation' due to delayed disclosure of audit findings. This is a regulatory announcement concerning compliance and penalties, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it falls under the fallback category for regulatory announcements.
2024-10-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.